...
首页> 外文期刊>BMC Anesthesiology >The median effective concentration (EC50) of propofol with different doses of fentanyl during colonoscopy in elderly patients
【24h】

The median effective concentration (EC50) of propofol with different doses of fentanyl during colonoscopy in elderly patients

机译:老年患者结肠镜检查期间不同剂量的芬太尼丙泊酚的中位有效浓度(EC50)

获取原文
           

摘要

Background Propofol and fentanyl are the most widely administered anesthesia maintaining drugs during colonoscopy. In this study, we determined the median effective concentration (EC50) of propofol required for colonoscopy in elderly patients, and the purpose of this study was to describe the pharmacodynamic interaction between fentanyl and propofol when used in combination for colonoscopy in elderly patients. Methods Ninety elderly patients scheduled for colonoscopy were allocated into three groups in a randomized, double-blinded manner as below, F0.5 group (0.5?μg.kg?1 fentanyl), F1.0 group (1.0?μg.kg?1 fentanyl) and saline control group. Anaesthesia was achieved by target-controlled infusion of propofol (Marsh model, with an initial plasma concentration of 2.0?μg.ml?1) and fentanyl. Colonoscopy was started 3?min after the injection of fentanyl. The EC50 of propofol for colonoscopy with different doses of fentanyl was measured by using an up-and-down sequential method with an adjacent concentration gradient at 0.5?μg.ml?1 to inhibit purposeful movements. Anaesthesia associated adverse events and recovery characters were also recorded. Results The EC50 of propofol for colonoscopy in elderly patients were 2.75?μg.ml?1 (95?% CI, 2.50–3.02?μg.ml?1) in F0.5 group, 2.05?μg.ml?1 (95?% CI, 1.98–2.13?μg.ml?1) in F1.0 group and 3.08?μg.ml?1 (95?% CI, 2.78–3.42?μg.ml?1) in control group respectively ( P Conclusion Increasing doses of fentanyl up to 1.0?μg.kg?1 reduces the propofol EC50 required for elderly patients undergoing colonoscopy, and there was no significant difference in anaesthesia associated adverse events but prolonged awake and discharge time. Trial registration Chinese Clinical Trial Registry ChiCTR15006368 . Date of registration: May 3, 2015. Keyword EC50 Propofol Fentanyl Elderly patients
机译:背景技术丙泊酚和芬太尼是结肠镜检查中应用最广泛的麻醉维持药物。在这项研究中,我们确定了老年患者结肠镜检查所需的丙泊酚中位数有效浓度(EC50),并且本研究的目的是描述芬太尼和丙泊酚联合用于老年人结肠镜检查时的药效学相互作用。方法将90例行结肠镜检查的老年患者随机分为三组,分别为F0.5组(0.5?μg.kg?1 芬太尼),F1.0组(F0.5组)。 1.0?μg.kg?1 芬太尼)和生理盐水对照组。麻醉是通过靶控输注异丙酚(Marsh模型,初始血浆浓度为2.0?μg.ml?1 )和芬太尼来实现的。注射芬太尼后3分钟开始结肠镜检查。采用上下顺序法,以0.5?μg.ml?1 的相邻浓度梯度抑制有目的的运动,测定不同剂量的芬太尼用于结肠镜检查的丙泊酚的EC50。还记录了与麻醉有关的不良事件和恢复特征。结果老年患者中丙泊酚用于结肠镜检查的EC50为2.75?μg.ml?1 (95%CI,2.50–3.02?μg.ml?1 )。 .5组,F1.0组为2.05?μg.ml?1 (95 %% CI,1.98–2.13?gg.ml ?1 )和3.08?g对照组.ml ?1 (95?%CI,2.78–3.42?μg.ml?1 )(P结论芬太尼剂量增加至1.0?μg .kg ?1 降低了老年结肠镜检查患者所需要的丙泊酚EC50,麻醉相关不良事件无明显差异,但清醒和排出时间延长。中国临床试验注册中心注册号为CTR15006368。注册:2015年5月3日。关键词EC50丙泊酚芬太尼老年患者

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号